Supplementary MaterialsSupplementary figure S1 and desk S1. in the G2/M stage, followed by activation of DNA and Wee1 harm response pathway. Conclusions: Our results identify UHRF1 like a encouraging prognostic marker for ESCC and suggest that UHRF1 may be a potential therapy target for ESCC patients with elevated UHRF1 expression. P PValueP /em 0.01). The… Continue reading Supplementary MaterialsSupplementary figure S1 and desk S1. in the G2/M stage,